Related Articles
Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer – PubMed
Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel – PubMed
Consistent evidence from numerous and multiple different types of clinical and genetic studies unequivocally establishes that LDL causes ASCVD.
Henry Ford Health dietitian: Boost healthy eating habits with homemade Lunchables
Many families are trying to figure out healthier alternatives to the convenient grab-and-go kits, keeping the same appeal to kids that Lunchables offers, while also…
2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Were you unable to attend APCCC 2024? Get all of the groundbreaking research, new guidelines, and the latest advances in urologic medicine you missed.
Study: AI is unreliable in assessing heart risk in emergencies – UPI.com
Artificial intelligence might be able to help doctors by filling out rote paperwork, but it’s not going to be useful in the ER anytime soon,…
Artificial intelligence helps in the detection of colon cancer
Artificial intelligence is being used by a growing number of doctors. Stephanie Stahl reports how it’s helping detect colon cancer.
What Are Karmic Relationships?
Hint: They aren’t nearly as romantic as they sound. A registered psychotherapist explains.
Patient Factors, Toxicities Key to Selecting NALIRIFOX or Other Chemo Options in Advanced Pancreatic Cancer
Kian-Huat Lim, MD, PhD, discusses the current treatment landscape for metastatic pancreatic cancer.
Inflammasome Therapeutics doses first patient in Phase 1 trial of Kamuvudine-8 for geographic atrophy
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
Digital health program cuts pre-term births by 20%
Through Ochsner Health’s Connected MOM program, 10.7% of patients are re-enrollees, signaling high satisfaction. Learn more with an AMA case study.